Usefulness of Balloon Aortic Valvuloplasty in the Management of Patients With Aortic Stenosis

Balloon aortic valvuloplasty to improve candidacy of patients evaluated for transcatheter aortic valve replacement

“…The low rate of complications noted in this study are likely due to a combination of patient selection, improved valve sizing by CT scan, improved procedural technique, and high volume operators performing the procedure. We reported a similarly low rate of complications (4%) in our prospective BAV study …”

“…Our group has recently reported the outcomes of a prospective study describing the outcomes of BAV based on assigned intent of the treating physician: bridge to decision (BTD), bridge to treatment (BTX), or palliation (PAL). 26 The evaluation of frailty in our study revealed interesting findings.…”

“…75% of the whole group and all 13 of the patients defined as frail by their criteria underwent definitive valve therapy. Our group has recently reported the outcomes of a prospective study describing the outcomes of BAV based on assigned intent of the treating physician: bridge to decision (BTD), bridge to treatment (BTX), or palliation (PAL) . Intent in our 100 study patients was 76 BTD; 20 BTX; and 4 PAL.…”

Safety and feasibility of balloon aortic valvuloplasty in non‐TAVI centers: The “BAV for life” experience

“…Unfortunately, due to the burden of multiple simultaneous comorbidities, left ventricular (LV) dysfunction, and advanced age, a large portion of these patients are ineligible even for TAVI . In this clinical setting, a medical treatment combined to a balloon aortic valvuloplasty (BAV) may represent a viable therapeutic strategy …”

“…3,4 In this clinical setting, a medical treatment combined to a balloon aortic valvuloplasty (BAV) may represent a viable therapeutic strategy. [5][6][7] Over the last two decades, there has been scant evidence on the short-and mid-term prognostic effects of BAV that, along with the relatively high number of peri-procedural complications, has tempered the use of this procedure in clinical practice. 8,9 Furthermore, the risk of severe acute aortic regurgitation (AR) requiring urgent TAVI has limited the diffusion of BAV procedure in all catheterization laboratories.…”